Latest Funding News

Culpeo Minerals reports significant progress in copper exploration across Chile with promising drilling results and a strategic acquisition of the Jupiter Project.

Locksley Resources has advanced its Mojave Project with critical drilling permits secured, a strategic $1.47 million capital raise, and a new U.S. OTCQB listing, setting the stage for maiden drilling campaigns targeting rare earths and antimony.

Patagonia Lithium has reported a remarkable 319% increase in its lithium resource at its Argentine project, alongside plans for further drilling and a $2.68 million capital raise to fund ongoing exploration.

Noble Helium advances its flagship North Rukwa helium project with a significant resource upgrade, rig exit at no cost, and new funding from key insiders, positioning for a leaner, data-driven drilling campaign.

Emerald Resources NL reported steady gold output at its Okvau Mine while unveiling significant resource expansions at its Dingo Range and Memot projects, alongside clearing its debt.

Tlou Energy Limited’s latest quarterly cash flow report reveals a cautious financial position with A$2.74 million in available funding, supporting approximately 2.5 quarters of operations as exploration activities continue.

Peak Minerals reports a significant expansion of heavy mineralisation at its Minta Rutile Project in Cameroon, alongside a $3.5 million strategic investment that fully funds its 2025 exploration plans.

VanEck Global Defence ETF, launched in September 2024, has reported a solid AUD 2.8 million profit in its first interim financial results ending January 2025, marking a promising start for the defence-focused fund.

Mamba Exploration Limited has decided to restart gold exploration at its Ashburton Project in Western Australia, backed by a strategic review and a cash position of $579,000. Historical data points to promising high-grade gold targets, setting the stage for a detailed exploration program.

Far East Gold has advanced drilling at its Bermol prospect in Indonesia, confirming key geological structures and preparing for expanded resource definition. The company also progresses copper-gold targets in Indonesia and maintains strong cash reserves to support ongoing exploration.

Noxopharm has initiated its HERACLES clinical trial for SOF-SKN, marking a key milestone for its Sofra platform, while deepening partnerships and actively seeking new funding to sustain development.

Opthea has discontinued its sozinibercept program after Phase 3 trial failures, leading to drastic staff cuts and a sharp decline in cash reserves amid ongoing funding negotiations.